Bassingthwaighte J, Beard D, Carlson B, Dash R, Vinnakota K
Ann Biomed Eng. 2012; 40(11):2379-98.
PMID: 22915334
PMC: 3471663.
DOI: 10.1007/s10439-012-0613-5.
Dilsizian V
J Nucl Cardiol. 2007; 14(3 Suppl):S97-9.
PMID: 17556185
DOI: 10.1016/j.nuclcard.2007.02.008.
Eckelman W, Babich J
J Nucl Cardiol. 2007; 14(3 Suppl):S100-9.
PMID: 17556177
DOI: 10.1016/j.nuclcard.2007.02.014.
Valkema R, van Eck-Smit B, van der Wall E
J Nucl Cardiol. 1994; 1(6):546-60.
PMID: 9420749
DOI: 10.1007/BF02939978.
Sinusas A
J Nucl Cardiol. 1994; 1(2 Pt 1):218-20.
PMID: 9420690
DOI: 10.1007/BF02984095.
Nuclear medicine at the crossroads.
Strauss H
Eur J Nucl Med. 1996; 23(6):697-704.
PMID: 8662106
DOI: 10.1007/BF00834534.
Beta-oxidation of 1-[14C]-17-[131I]-iodo-heptadecanoic acid following intracoronary injection in humans results in similar release of both tracers.
Henrich M, Grossmann K, Motz W, Vogt M, Vester E, Holschbach M
Eur J Nucl Med. 1993; 20(3):225-30.
PMID: 8462611
DOI: 10.1007/BF00170003.
Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium.
Machulla H, Marsmann M, Dutschka K
Eur J Nucl Med. 1980; 5(2):171-3.
PMID: 7379820
DOI: 10.1007/BF00252480.
A comparison between terminally radioiodinated hexadecenoic acid (125I-HA) and heptadecanoic acid (131I-H0A) in the dog heart.
van der Wall E, Westera G, Heidendal G, den Hollander W
Eur J Nucl Med. 1981; 6(12):581-4.
PMID: 7333321
DOI: 10.1007/BF00252673.
External detection of regional myocardial metabolism with radioiodinated hexadecenoic acid in the dog heart.
van der Wall E, Westera G, den Hollander W, Visser F
Eur J Nucl Med. 1981; 6(4):147-51.
PMID: 7215379
DOI: 10.1007/BF00253163.
I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary study.
van der Wall E, Heidendal G, den Hollander W, Westera G, ROOS J
Eur J Nucl Med. 1980; 5(5):401-5.
PMID: 7215360
DOI: 10.1007/BF00261781.
Myocardial kinetics of 123I-labeled-16-hexadecanoic acid.
Okada R, Elmaleh D, Werre G, Strauss H
Eur J Nucl Med. 1983; 8(5):211-7.
PMID: 6873097
DOI: 10.1007/BF00253768.
The use of 123I-labeled heptadecanoic acid (HDA) as metabolic tracer: preliminary report.
Dudczak R, Kletter K, FRISCHAUF H, Losert U, Angelberger P, Schmoliner R
Eur J Nucl Med. 1984; 9(2):81-5.
PMID: 6368234
DOI: 10.1007/BF00254442.
Tellurium-labeled fatty-acid analogs: relationship of heteroatom position to myocardial kinetics.
Okada R, Knapp Jr F, Goodman M, Elmaleh D, Strauss H
Eur J Nucl Med. 1985; 11(5):156-61.
PMID: 4065154
DOI: 10.1007/BF00251366.
Do iodinated fatty acids undergo a nonspecific deiodination in the myocardium?.
Cuchet P, Demaison L, Bontemps L, Keriel C, MATHIEU J, Pernin C
Eur J Nucl Med. 1985; 10(11-12):505-10.
PMID: 4029208
DOI: 10.1007/BF00252742.
Metabolism of 15 (p 123I iodophenyl-)pentadecanoic acid in heart muscle and noncardiac tissues.
Reske S, Sauer W, Machulla H, Knust J, Winkler C
Eur J Nucl Med. 1985; 10(5-6):228-34.
PMID: 3987699
DOI: 10.1007/BF00254466.
I-123 heptadecanoic acid--value and limitations in comparison with C-11 palmitate.
Schon H
Eur J Nucl Med. 1986; 12 Suppl:S16-9.
PMID: 3490371
DOI: 10.1007/BF00258096.
Cardiac nuclear medicine: positron emission tomography in clinical medicine.
Kaiser K, Feinendegen L
Eur J Nucl Med. 1988; 13(12):648-52.
PMID: 3282887
DOI: 10.1007/BF00256392.
Myocardial scintigraphy--25 years after start.
Hor G
Eur J Nucl Med. 1988; 13(12):619-36.
PMID: 3282885
DOI: 10.1007/BF00256390.
Regional rates of myocardial fatty acid metabolism: comparison with coronary angiography and ventriculography.
SCHAD N, Wagner R, Hallermeier J, Daus H, Vattimo A, Bertelli P
Eur J Nucl Med. 1990; 16(4-6):205-12.
PMID: 2351168
DOI: 10.1007/BF00842770.
